Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

Table 1

Clinical data of studied cases.

		No.	%
Sex	Male	8	53.33
	Female	7	46.66
Age (years)	Mean ± SD	33.8 ± 10.10
	Min-max	18–56
Family history	Negative	12	80.00
	Positive	3	20.00
Type of skin	III	10	66.66
	IV	5	33.33
Previous history of treatment	Yes	15	100
	No	0	0